GlassScriptPhysician profile
Robert James Duggan
NPI 1538158670
$4,467.09
in general payments reported to CMS, 2019-2025
43 companies · $904 in 2025
The $904 reported for 2025 was more than what 78% of Podiatrist providers received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,130 · 2020: $575 · 2021: $649 · 2022: $529 · 2023: $398 · 2024: $282 · 2025: $904.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,584.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,583.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medartis INC. | $597.99 | 2019-2021 | |
| Arthrex, INC. | $579.60 | 2025 | |
| Smith+Nephew, INC. | $387.41 | 2019-2025 | Collagenase Santyl, Renasys Go V2 Home, Renasys Touch |
| Zimmer Biomet Holdings, INC. | $326.23 | 2019-2024 | Tapestry |
| Melinta Therapeutics, LLC | $239.62 | 2019-2022 | |
| Organogenesis INC. | $209.56 | 2021-2023 | Puraply |
| Abbvie INC. | $201.13 | 2021-2023 | Dalvance |
| Triad Life Sciences INC. | $177.96 | 2022 | |
| Acera Surgical, INC. | $174.51 | 2021 | |
| Janssen Pharmaceuticals, INC | $159.26 | 2019 | |
| Sanara Medtech INC. | $135.88 | 2025 | Celleraterx |
| Arthrosurface Incorporated | $125.00 | 2019 | |
| Polarityte, INC. | $111.49 | 2020 | |
| Misonix INC | $96.03 | 2021 | |
| Reddress USA, INC. | $95.20 | 2024 |
Show all 43 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Reel Surgical, INC. | $73.74 | 2025 | |
| Integra Lifesciences Corporation | $64.04 | 2020-2025 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Heron Therapeutics, INC. | $54.10 | 2023 | Zynrelef |
| Convatec INC. | $52.13 | 2020-2022 | |
| Tactile Systems Technology INC | $49.04 | 2023 | Flexitouch Plus, Entre Plus |
| Kerecis Limited | $46.63 | 2021-2023 | Kerecis Omega3 Surgiclose, Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide |
| Pacira Pharmaceuticals Incorporated | $43.72 | 2021-2022 | |
| Trilliant Surgical LLC. | $42.46 | 2019 | |
| Bioventus LLC | $34.23 | 2023-2024 | Exogen Ultrasound Bone Healing System, Theragenesis Bilayer Wound Matrix |
| Ossio INC | $33.72 | 2020 | |
| Boston Scientific Corporation | $31.88 | 2019 | |
| Treace Medical Concepts, INC. | $31.12 | 2023 | |
| Vertex Pharmaceuticals Incorporated | $29.31 | 2025 | |
| Access Pro Medical, LLC | $25.82 | 2023 | Matriderm |
| Acell, INC. | $23.44 | 2019 | |
| Davol INC. | $23.07 | 2021 | |
| Zimvie INC. | $22.48 | 2023 | |
| Depuy Synthes Sales INC. | $20.51 | 2019 | |
| Medtronic, INC. | $20.43 | 2021 | |
| Endo Pharmaceuticals INC. | $17.20 | 2024 | Xiaflex |
| Kci USA, INC. | $16.06 | 2020 | |
| Dexcom, INC. | $15.09 | 2021 | |
| Paragon 28, INC. | $14.81 | 2021 | |
| Baudax Bio INC. | $14.07 | 2020 | |
| Orthofix Medical, INC. | $14.06 | 2025 | Physio-Stim |
| Paratek Pharmaceuticals, INC. | $12.74 | 2023 | Nuzyra |
| Next Science LLC | $12.57 | 2021 | |
| Zyla Life Sciences, INC. | $11.75 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Duggan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.